Literature DB >> 11114492

Hippocampal perfusion in mild Alzheimer's disease.

G Rodriguez1, P Vitali, P Calvini, C Bordoni, N Girtler, G Taddei, G Mariani, F Nobili.   

Abstract

Perfusion and metabolic studies in patients with Alzheimer's disease (AD) have so far yielded conflicting results on the functional status of the hippocampal region, whose deep location in the brain makes it critical to optimize the image-reconstruction technique employed in emission tomography. We used a brain-dedicated device (CERASPECT) to perform single photon emission computed tomography (SPECT) studies with 99mTc-hexamethylpropylene-amine-oxime in 22 consecutive patients (mean age: 74+/-6.5 years) with mild [mini-mental status examination (MMSE) score > or =15, mean 20.8+/-3.2], probable AD. The control subjects were 11 healthy elderly people (mean age: 70.5+/-6.5 years). In patients, the total score on the selective reminding test (SRT) was used as an index of memory function. Counts from a hippocampal and a temporoparietal region of interest in each hemisphere were referred to the average thalamic counts. To optimize SPECT images, we used conventional filtered back-projection (FBP) reconstruction and a new iterative method of conjugate gradients (CG), which takes into account the geometrical and physical characteristics of the gamma-camera. Hippocampal perfusion in the two hemispheres was significantly lower in patients than in control subjects, regardless of which reconstruction method was used, and correlated with the MMSE score. The correlation between hippocampal perfusion and the SRT score was significantly (bootstrap procedure) higher with the CG method than with the FBP method (CG: r=0.52 and 0.54; FBP: r=0.39 and 0.47, for the right and left hemisphere, respectively). These results show hippocampal hypoperfusion in patients with mild AD, a correlation between hippocampal perfusion and the severity of cognitive impairment, and enhanced identification of these subtle perfusional changes with the use of an alternative image-reconstruction method that improves the spatial resolution of SPECT images.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11114492     DOI: 10.1016/s0925-4927(00)00071-8

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  20 in total

Review 1.  The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment.

Authors:  G Stennis Watson; Suzanne Craft
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

2.  99mTc-HMPAO and 99mTc-ECD perform differently in typically hypoperfused areas in Alzheimer's disease.

Authors:  Pierre Malick Koulibaly; Flavio Nobili; Octave Migneco; Paolo Vitali; Philippe H Robert; Nicola Girtler; Jacques Darcourt; Guido Rodriguez
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-15       Impact factor: 9.236

3.  Diagnosis of suspected Alzheimer's disease is improved by automated analysis of regional cerebral blood flow.

Authors:  Bich-Ngoc-Thanh Tang; Satoshi Minoshima; Jean George; Annie Robert; Christian Swine; Patrice Laloux; Thierry Vander Borght
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-01       Impact factor: 9.236

4.  Global cognitive impairment should be taken into account in SPECT-neuropsychology correlations: the example of verbal memory in very mild Alzheimer's disease.

Authors:  G Rodriguez; S Morbelli; A Brugnolo; P Calvini; N Girtler; A Piccardo; N J Dougall; K P Ebmeier; J C Baron; F Nobili
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-06-02       Impact factor: 9.236

Review 5.  Neuropsychological contributions to the early identification of Alzheimer's disease.

Authors:  Mark W Bondi; Amy J Jak; Lisa Delano-Wood; Mark W Jacobson; Dean C Delis; David P Salmon
Journal:  Neuropsychol Rev       Date:  2008-03-18       Impact factor: 7.444

6.  Do cognitive patterns of brain magnetic activity correlate with hippocampal atrophy in Alzheimer's disease?

Authors:  F Maestú; J Arrazola; A Fernández; P G Simos; C Amo; P Gil-Gregorio; S Fernandez; A Papanicolaou; T Ortiz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

7.  Modifications of tau protein after cerebral ischemia and reperfusion in rats are similar to those occurring in Alzheimer's disease - Hyperphosphorylation and cleavage of 4- and 3-repeat tau.

Authors:  Hiroki Fujii; Tetsuya Takahashi; Tomoya Mukai; Shigeru Tanaka; Naohisa Hosomi; Hirofumi Maruyama; Norio Sakai; Masayasu Matsumoto
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

8.  Imaging improves diagnosis of dementia with lewy bodies.

Authors:  Masaru Tateno; Seiju Kobayashi; Toshikazu Saito
Journal:  Psychiatry Investig       Date:  2009-11-21       Impact factor: 2.505

9.  Hippocampal hyperperfusion in Alzheimer's disease.

Authors:  David C Alsop; Melynda Casement; Cedric de Bazelaire; Tamara Fong; Daniel Z Press
Journal:  Neuroimage       Date:  2008-06-17       Impact factor: 6.556

10.  The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimer's Disease.

Authors:  S L Cole; R Vassar
Journal:  Curr Genomics       Date:  2007-12       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.